36748 Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices 

www.regulations.gov, including any 

personal and/or business confidential 

information provided. To confirm 

receipt of your comment(s), please 

check www.regulations.gov, 

approximately two-to-three days after 

submission to verify posting. If there are 

difficulties submitting comments, 

contact the GSA Regulatory Secretariat 

Division at 202–501–4755 or 

GSARegSec@gsa.gov. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Zenaida Delgado, Procurement Analyst, 

at telephone 202–969–7207, or email 

zenaida.delgado@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. OMB Control Number, Title, and any 

Associated Form(s) 

9000–0010, Progress Payments (SF 

1443), Standard Form 1443, Contractor’s 

Request for Progress Payment. 

B. Need and Uses 

This clearance covers the information 

that contractors must submit to comply 

with the following Federal Acquisition 

Regulation (FAR) requirements: 

• FAR 52.232–16, Progress Payments, 

and Standard Form (SF) 1443, 

Contractor’s Request for Progress 

Payment. 

Paragraph (g) of this FAR clause 

requires contractors to furnish reports, 

certificates, financial statements, and 

other pertinent information (including 

estimates to complete) reasonably 

requested by contracting officers for the 

administration of fixed-price contracts 

under which the Government will 

provide progress payments based on 

costs. Each request for progress payment 

shall be submitted on a SF 1443. 

Contracting officers use this 

information to administer progress 

payments under a contract. This 

collection of information is necessary 

for protection of the Government against 

financial loss through making of 

progress payments. 

C. Annual Burden 

Respondents: 11,804. 

Total Annual Responses: 377,728. 

Total Burden Hours: 158,646. 

D. Public Comment 

A 60-day notice was published in the 

Federal Register at 86 FR 22207, on 

April 27, 2021. No comments were 

received. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division, by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 9000–0010, Progress 

Payments (SF 1443). 

Janet Fry, 

Director, Federal Acquisition Policy Division, 

Office of Governmentwide Acquisition Policy, 

Office of Acquisition Policy, Office of 

Governmentwide Policy. 

[FR Doc. 2021–14852 Filed 7–12–21; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number CDC–2021–0067, NIOSH– 

342] 

Draft—Approaches to Developing 

Occupational Exposure Limits or 

Bands for Engineered Nanomaterials: 

User Guide and Technical Report 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for comment. 

SUMMARY: NIOSH announces the 

availability of a draft technical report 

entitled Approaches to Developing 

Occupational Exposure Limits or Bands 

for Engineered Nanomaterials: User 

Guide and Technical Report now 

available for public comment. To view 

the notice and related materials, visit 

https://www.regulations.gov and enter 

CDC–2021–0067 in the search field and 

click ‘‘Search.’’ 

DATES: Electronic or written comments 

must be received by September 13, 

2021. 

ADDRESSES: You may submit comments, 

identified by CDC–2021–0067 and 

docket number NIOSH–342, by any of 

the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov Follow the 

instructions for submitting comments. 

• Mail: National Institute for 

Occupational Safety and Health, NIOSH 

Docket Office, 1090 Tusculum Avenue, 

MS C–34, Cincinnati, Ohio 45226–1998. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

[CDC–2021–0067; NIOSH–342]. All 

relevant comments received will be 

posted without change to https://

www.regulations.gov, including any 

personal information provided. All 

electronic comments should be 

formatted as Microsoft Word. For access 

to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. All 

information received in response to this 

notice will also be available for public 

examination and copying at the NIOSH 

Docket Office, 1150 Tusculum Avenue, 

Room 155, Cincinnati, OH 45226–1998. 

FOR FURTHER INFORMATION CONTACT: 

Nathan Drew, National Institute for 

Occupational Safety and Health, 

Emerging Technologies Branch, 1090 

Tusculum Avenue, MS C–14, 

Cincinnati, OH 45226, telephone (513) 

533–8352 (not a toll free number). 

SUPPLEMENTARY INFORMATION: On 

December 17, 2019, the National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention announced in the Federal 

Register [84 FR 68935] plans to evaluate 

the scientific data on engineered 

nanomaterials for the development of 

categorical occupational exposure 

limits. The draft NIOSH technical report 

describing approaches to evaluating 

these scientific data is now available for 

public comment, Approaches to 

Developing Occupational Exposure 

Limits or Bands for Engineered 

Nanomaterials: User Guide and 

Technical Report. 

Background: Most chemical 

substances, including engineered 

nanomaterials, do not have specific 

occupational exposure limits. 

Alternative methods are needed to 

assess the potential occupational safety 

and health hazards of engineered 

nanomaterials. Categorical occupational 

exposure limits are one approach to 

estimating exposure concentrations for 

groups of materials with similar 

toxicological effects and/or 

physicochemical properties. 

Occupational exposure banding is 

another approach to protect worker 

health by assigning chemical substances 

into specific categories or ‘‘bands’’ 

based on their associated health 

outcomes and on potency 

considerations. These bands correspond 

to a range of airborne exposure 

concentrations to inform risk 

management decisions for substances 

that do not have occupational exposure 

limits. NIOSH has proposed an 

evidence-based approach to evaluate the 

scientific information available in order 

to derive occupational exposure limits, 

or bands, for engineered nanomaterials. 

This proposed approach is described in 

the draft NIOSH technical report 

available for public comment, 

Approaches to Developing Occupational 

Exposure Limits or Bands for 

Engineered Nanomaterials: User Guide 

and Technical Report. This draft report 

contains two main parts: (I) User Guide 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices 36749 

1We note that the Citizen’s Advisory Panel on 

Medicare Education is also referred to as the 

Advisory Panel on Medicare Education (65 FR 

4617). The name was updated in the Second 

Amended Charter approved on July 24, 2000. 

and (II) full Technical Report and 

Appendixes. 

The purpose of the public comment 

period is to obtain comments on the 

draft report. Comments are being sought 

from individuals including scientists 

and representatives from various 

government agencies, industry, labor, 

and other stakeholders, and also the 

public. If there are errors of fact, 

unsubstantiated claims, evidence of 

careless experimental work, inclusion of 

too much information already in the 

literature, or statements that are 

inaccurate, please note such in your 

review comments. 

The authors ask that special emphasis 

be placed on technical review of the 

following issues: 

1. Does the draft document adequately 

describe the process for gathering and 

evaluating the information available on 

occupational exposure limits or bands 

for engineered nanomaterials? 

2. Does the draft document adequately 

describe the development of a 

framework for categorizing engineered 

nanomaterials by potential occupational 

health hazard from inhalation exposure? 

3. Are the clustering and classification 

modeling methodologies reasonable for 

these data? 

4. Is a revision to current occupational 

exposure banding guidance needed to 

incorporate a band F? 

5. How useful and practical is the 

approach described in both the user 

guide and full technical report for 

deriving categorical occupational 

exposure limits, and what are the 

opportunities for improvement? 

6. Are the current searches and 

collection of scientific data sufficient, 

and are there additional opportunities 

for obtaining data that were not 

included? 

7. Would the methods used in the 

report also be appropriate for a future 

comprehensive dataset of experimental, 

toxicological, and physicochemical 

information for engineered 

nanomaterials? 

8. Are there additional comments that 

you would like to provide? 

John J. Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2021–14801 Filed 7–12–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–7063–N] 

Announcement of the Advisory Panel 

on Outreach and Education (APOE) 

July 28, 2021 Virtual Meeting 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces the 

next meeting of the APOE (the Panel) in 

accordance with the Federal Advisory 

Committee Act. The Panel advises and 

makes recommendations to the 

Secretary of the U.S. Department of 

Health and Human Services (HHS) (the 

Secretary) and the Administrator of the 

Centers for Medicare & Medicaid 

Services (CMS) on opportunities to 

enhance the effectiveness of consumer 

education strategies concerning the 

Health Insurance Marketplace®, 

Medicare, Medicaid, and the Children’s 

Health Insurance Program (CHIP). This 

meeting is open to the public. 

DATES: 

Meeting Date: Wednesday, July 28, 

2021 from 12:00 p.m. to 5:00 p.m. 

eastern daylight time (e.d.t). 

Deadline for Meeting Registration, 

Presentations, Special 

Accommodations, and Comments: 

Wednesday, July 14, 2021, 5:00 p.m. 

(e.d.t). 

ADDRESSES: 

Meeting Location: Virtual. All those 

who RSVP will receive the link to 

attend. 

Presentations and Written Comments: 

Presentations and written comments 

should be submitted to: Lisa Carr, 

Designated Federal Official (DFO), 

Office of Communications, Centers for 

Medicare & Medicaid Services, 200 

Independence Avenue SW, Mailstop 

325G HHH, Washington, DC 20201, 

202–690–5742, or via email at APOE@

cms.hhs.gov. 

Registration: The meeting is open to 

the public, but attendance is limited to 

the space available. Persons wishing to 

attend this meeting must register at the 

website https://www.eventbrite.com/e/ 

apoe-july-28-2021-virtual-meetingtickets-151112584809 or by contacting 

the DFO listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice, by the date listed in the DATES

section of this notice. Individuals 

requiring sign language interpretation or 

other special accommodations should 

contact the DFO at the address listed in 

the ADDRESSES section of this notice by 

the date listed in the DATES section of 

this notice. 

FOR FURTHER INFORMATION CONTACT: Lisa 

Carr, Designated Federal Official, Office 

of Communications, 200 Independence 

Avenue SW, Mailstop 325G HHH, 

Washington, DC 20201, 202–690–5742, 

or via email at APOE@cms.hhs.gov. 

Additional information about the 

APOE is available at: https://

www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE. Press 

inquiries are handled through the CMS 

Press Office at (202) 690–6145. 

SUPPLEMENTARY INFORMATION: 

I. Background and Charter Renewal 

Information 

A. Background 

The Advisory Panel for Outreach and 

Education (APOE) (the Panel) is 

governed by the provisions of the 

Federal Advisory Committee Act 

(FACA) (Pub. L. 92–463), as amended (5 

U.S.C. Appendix 2), which sets forth 

standards for the formation and use of 

federal advisory committees. The Panel 

is authorized by section 1114(f) of the 

Social Security Act (the Act) (42 U.S.C. 

1314(f)) and section 222 of the Public 

Health Service Act (42 U.S.C. 217a). 

The Secretary of the U.S. Department 

of Health and Human Services (HHS) 

(the Secretary) signed the charter 

establishing the Citizen’s Advisory 

Panel on Medicare Education 1 (the 

predecessor to the APOE) on January 21, 

1999 (64 FR 7899) to advise and make 

recommendations to the Secretary and 

the Administrator of the Centers for 

Medicare & Medicaid Services (CMS) on 

the effective implementation of national 

Medicare education programs, including 

with respect to the Medicare+Choice 

(M+C) program added by the Balanced 

Budget Act of 1997 (Pub. L. 105–33). 

The Medicare Prescription Drug, 

Improvement, and Modernization Act of 

2003 (MMA) (Pub. L. 108–173) 

expanded the existing health plan 

options and benefits available under the 

M+C program and renamed it the 

Medicare Advantage (MA) program. 

CMS has had substantial responsibilities 

to provide information to Medicare 

beneficiaries about the range of health 

plan options available and better tools 

to evaluate these options. The 

successful MA program implementation 

required CMS to consider the views and 

policy input from a variety of private 


jbell on DSKJLSW7X2PROD with NOTICES